查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990537

切除术市场：2026-2032年全球预测（按适应症、手术方法、手术流程和最终用户划分）

Colectomy Procedures Market by Indication, Surgical Approach, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，切除术市场价值将达到 19.5 亿美元，到 2026 年将成长到 20.5 亿美元，到 2032 年将达到 28.6 亿美元，复合年增长率为 5.57%。

主要市场统计数据
基准年 2025 19.5亿美元
预计年份：2026年 20.5亿美元
预测年份 2032 28.6亿美元
复合年增长率 (%) 5.57%

对切除术护理的最新趋势进行了权威概述，将临床实践的演变、新技术的引入和医疗保健决策的趋势联繫起来。

本执行摘要全面检验了切除术技术，整合了影响医疗实践和采购的临床趋势、手术流程演变以及相关人员动态。分析说明探讨外科技术进步、手术全期照护路径和医疗设备创新如何与医疗服务提供者的工作流程和病患期望相交织，进而影响临床医师和组织层面的决策。

切除术治疗正迎来一个关键的转折点，这得益于微创技术、重新设计的手术流程以及以结果为导向的临床实践的发展。

切除术领域正经历着一场变革，其驱动力来自技术进步、不断完善的临床指南以及对基于价值的治疗结果日益增长的重视。微创手术透过改善器械和视觉化技术，以及更深入地融入以早期復健和减少资源消耗为优先的手术全期流程，不断拓展其临床应用范围。这种临床发展动能正推动机器人辅助切除术从小众应用发展成为某些复杂切除术的首选方案，促使人们重新评估培训课程和资本投资计画。

美国近期关税调整对切除术相关技术的筹资策略、供应链韧性和供应商关係产生了哪些影响？

在美国，近期关税政策的调整为参与切除术相关手术器械、机器人平台和一次性医疗设备组件采购的相关人员带来了更多复杂性。这些政策变化正在影响医院系统和门诊网路的采购週期、供应商合约策略和资本支出计划。拥有集中采购团队的医疗机构正优先考虑合约重新谈判和总体拥有成本 (TCO) 评估，以减轻对采购的即时影响，同时确保临床能够获得优先技术。

从细分观点主导，将适应症、手术细节、手术方法和临床环境与对医疗设备、训练和临床路径的实际影响联繫起来。

细分市场分析揭示了每种适应症、手术方法、手术类型和终端用户环境的不同临床和商业性路径，每种路径都会对技术应用和医疗服务产生独特的影响。基于适应症，我们针对癌症、克隆氏症、憩室病和溃疡性大肠炎进行了市场调查，这种分布反映了临床优先事项。肿瘤切除术需要遵循肿瘤学原则，并在适用情况下进行淋巴结清除。发炎性肠道疾病通常需要复杂的决策，以保留肠道长度并控制慢性发炎变化。同时，对于憩室病和急性併发症，快速控制病灶和减少併发症至关重要。

对美洲、欧洲、中东和非洲以及亚太地区的医疗保健发展、能力扩张和采购趋势进行区域比较分析。

区域趋势正对临床实践模式、报销框架和医疗设备部署物流产生实际影响，在美洲、欧洲、中东和非洲以及亚太地区形成了各自独特的格局。在美洲，私部门与综合医疗系统竞争，推动对微创和机器人手术能力的投资，同时兼顾手术全期效率和病患体验。该地区的医疗服务提供者经常参与集中采购咨询和以价值为导向的试验计画，这些项目影响医疗设备的选择和服务合约模式。

竞争优势、一体化服务交付和实证商业模式如何重新定义整个切除术生态系统的企业策略。

切除术生态系统的企业级趋势揭示了一个由产品差异化、服务模式和伙伴关係策略共同塑造的竞争格局。领先的医疗设备製造商正优先考虑系统整合、循证医学证据产生以及以外科医生为中心的支持，以实现产品差异化。这包括投资于模组化器械、优化工作流程的一次性产品以及支援手术全期计划和结果追踪的数位化能力。

为医疗服务提供者和相关人员提供切实可行的策略措施，以加快安全部署、控製成本，并使临床结果与商业性框架保持一致。

行业领导者可以将观察到的趋势转化为具体的倡议，使临床品质与营运和商业性目标保持一致。首先，他们应优先投资于临床医生培训项目，以加速微创和机器人辅助手术技术的安全应用，同时融入促进復原的原则，从而提高处理能力和患者疗效。系统化的教学、模拟和基于能力的认证体係可以减少差异，并实现可预测的专案规模化。

结合临床证据、相关人员访谈和对医疗设备效能的洞察，采用混合方法研究框架，可以得出平衡、可操作的结论。

本执行摘要的研究整合了同行评审的临床文献、指南、手术註册资料、医疗设备技术文檔，以及对多个地区临床和供应链领导者的访谈。研究采用混合方法，结合定性访谈和主题分析，以识别实践中的障碍和促进因素；同时，对临床证据和医疗设备特性进行系统性回顾，为它们对手术和培训的影响提供技术背景。

整合临床、营运和商业性需求，为医疗机构在不断变化的切除术。

总之，切除术技术正处于一个策略性的十字路口，临床创新、营运模式重塑和商业性动态在此交汇，为医疗服务提供者和产业伙伴带来机会和挑战。微创和机器人辅助手术技术持续推动临床能力的提升，而市场和政策压力则凸显了采购中灵活且注重成本效益的部署策略的重要性。适应症特定要求、手术多样性和最终用户环境之间的相互作用，要求采用量身定制的方法，在满足临床细微差别的同时，实现可扩展的部署。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：切除术市场：依适应症划分

  • 癌症
  • 克隆氏症
  • 憩室病
  • 溃疡性大肠炎

第九章：依手术入路分類的切除术市场

  • 微创
    • 腹腔镜
    • 机器人支援
  • 开放性手术

第十章：依手术类型切除术市场

  • 部分切除术
    • 左半切除术
    • 右半切除术
    • 切除术
    • 横结肠半切除术
  • 切除术
  • 全切除术

第十一章：切除术市场：依最终用户划分

  • 门诊手术中心
  • 医院外科中心
  • 门诊部

第十二章：切除术市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：切除术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：切除术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国切除术市场

第十六章 中国切除术市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Applied Medical Resources Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Colospan Ltd.
  • CONMED Corporation
  • Cook Group Incorporated
  • CooperSurgical Inc.
  • Fujifilm Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johns Hopkins Medicine
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • NuVasive, Inc.
  • Olympus Corporation
  • SafeHeal SAS
  • Smith & Nephew PLC
  • Stryker Corporation
  • Virtual Incision Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-6A132FD32B20

The Colectomy Procedures Market was valued at USD 1.95 billion in 2025 and is projected to grow to USD 2.05 billion in 2026, with a CAGR of 5.57%, reaching USD 2.86 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.95 billion
Estimated Year [2026] USD 2.05 billion
Forecast Year [2032] USD 2.86 billion
CAGR (%) 5.57%

An authoritative orientation to current developments in colectomy care that bridges clinical practice evolution, technology adoption, and institutional decision-making dynamics

This executive summary introduces a comprehensive examination of colectomy procedures, synthesizing clinical trends, procedural evolution, and stakeholder dynamics that shape practice and procurement across care settings. The analysis centers on how advances in surgical technique, perioperative care pathways, and device innovation intersect with provider workflows and patient expectations to influence decision-making at the clinician and organizational level.

The objective is to provide a succinct yet systematic narrative that helps clinical leaders, hospital administrators, device innovators, and policy stakeholders navigate an increasingly complex landscape. Through evidence-informed observations and cross-disciplinary interpretation, the summary highlights points of inflection where clinical practice and industry strategy converge, framing actionable implications without prescriptive recommendations that require institution-level validation.

Readers will find an integrated perspective that connects clinical indications and procedural approaches to end-user environments and regional dynamics. This introduction sets the stage for deeper sections that analyze transformative shifts, tariff-related impacts, segmentation-derived insights, regional variation, company-level dynamics, recommended actions, and the methodology underpinning the findings.

Key inflection points in colectomy care driven by the convergence of minimally invasive technologies, operational redesign, and evolving outcome-focused clinical practice

The landscape of colectomy procedures is undergoing transformative shifts driven by technological refinement, evolving clinical guidelines, and a growing emphasis on value-based outcomes. Minimally invasive approaches have continued to expand their clinical footprint, not only because of improvements in instrumentation and visualization but also due to deeper integration of perioperative pathways that emphasize early recovery and reduced resource utilization. Alongside this clinical momentum, robotic assistance has matured from niche application to a prominent option for selected complex resections, prompting reassessment of training curricula and capital planning.

Concurrently, patient expectations and payer frameworks are reshaping how care is delivered. Enhanced recovery protocols, outpatient-facing pathways, and same-day surgery feasibility are prompting institutions to redesign admission, discharge, and follow-up processes to optimize throughput while maintaining safety. These operational shifts are aligned with efforts to measure outcomes that matter to patients, including functional recovery and quality-of-life metrics, which in turn influence procedural selection and device adoption.

Finally, the interplay between technological innovation and workforce readiness is redefining competency models for colorectal surgery. Simulation, modular credentialing, and multidisciplinary team integration are emerging as practical enablers for safely expanding minimally invasive and robotic programs. This confluence of clinical, operational, and educational trends marks a departure from incremental change toward coordinated transformation across the care continuum.

How recent tariff adjustments in the United States are reshaping procurement strategies, supply chain resilience, and vendor relationships for colectomy-related technologies

In the United States, recent tariff policy adjustments have introduced an additional layer of complexity for stakeholders involved in procuring surgical instrumentation, robotic platforms, and disposable device components relevant to colectomy procedures. These policy changes have influenced procurement cycles, vendor contracting strategies, and capital planning conversations within hospital systems and ambulatory networks. Institutions with centralized purchasing teams have prioritized contract renegotiation and total-cost-of-ownership evaluations to mitigate the immediate procurement effects while preserving clinical access to preferred technologies.

The cumulative impact has been moderated by several adaptive responses. Clinical teams and supply chain leaders have collaborated more closely to identify clinically equivalent device alternatives, optimize inventory management, and stagger capital acquisition to reduce exposure to tariff-driven price volatility. Additionally, manufacturers and distributors have taken steps to revise commercial terms, localize certain supply chain nodes where feasible, and provide bundled service models that emphasize predictable lifecycle costs and training support.

Looking ahead, sustained tariff-driven pressures are accelerating consideration of regional sourcing strategies and device standardization where clinically appropriate. Stakeholders are balancing the need to maintain advances in minimally invasive and robotic capabilities against the financial imperative to control procedural costs, thereby reinforcing the importance of comprehensive procurement frameworks that align clinical priorities with fiscal stewardship.

Segmentation-driven perspectives that map indications, procedural nuances, surgical approaches, and care settings to practical implications for devices, training, and clinical pathways

Segmentation insights reveal differentiated clinical and commercial pathways across indications, surgical approaches, procedure types, and end-user environments, each carrying distinct implications for technology adoption and care delivery. Based on Indication, market is studied across Cancer, Crohn's Disease, Diverticular Disease, and Ulcerative Colitis, and this distribution informs clinical priorities: oncologic resections demand oncologic principles and lymphadenectomy where applicable, inflammatory bowel disease often requires complex decision-making around preserving bowel length and managing chronic inflammatory changes, while diverticular disease and acute complications emphasize timely source control and complication mitigation.

Based on Surgical Approach, market is studied across Minimally Invasive and Open Surgery. The Minimally Invasive is further studied across Laparoscopic and Robotic Assisted, and these distinctions shape resource needs and training trajectories. Laparoscopic techniques remain foundational for many resections, offering reproducible outcomes with established instrumentation, whereas robotic assistance is leveraged for ergonomic advantages, three-dimensional visualization, and articulated instrument control in anatomically constrained or technically demanding situations. Open surgery retains a vital role for complex emergencies, multi-visceral resections, and scenarios where tactile feedback and rapid exposure are priorities.

Based on Procedure Type, market is studied across Partial Colectomy, Proctocolectomy, and Total Colectomy. The Partial Colectomy is further studied across Left Hemicolectomy, Right Hemicolectomy, Sigmoid Colectomy, and Transverse Hemicolectomy, and this granular typology aligns with variations in operative time, perioperative pathways, and device utilization. Different resection types impose distinct requirements for anastomotic technique, specimen extraction methods, and risk mitigation strategies for complications such as anastomotic leak and postoperative ileus.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospital Surgical Centers, and Outpatient Clinics, and these settings influence workflow design, capital allocation, and care pathway configuration. Ambulatory surgical centers and outpatient clinics are increasingly significant for streamlined procedures and recovery-focused pathways, while hospital surgical centers remain central for complex resections, thoracoabdominal approaches, and high-acuity perioperative management. Understanding these segmentation layers enables stakeholders to tailor training, device bundles, and service models to the clinical and operational realities of each setting.

A comparative regional analysis of practice evolution, capacity expansion, and procurement dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics exert tangible influence on clinical practice models, reimbursement frameworks, and the logistics of device deployment, yielding distinctive patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, integrated health systems and a competitive private sector have driven investment in minimally invasive and robotic capacities, coupled with attention to perioperative efficiency and patient experience. Providers in this region frequently engage in centralized purchasing discussions and value-based pilot programs that shape device selection and service contracting models.

Europe, Middle East & Africa presents a heterogeneous picture where national health system structures, regulatory environments, and workforce distribution result in varied adoption rates. In many countries within this broad region, constrained capital allocation and differing reimbursement incentives emphasize cost-effectiveness and regional centers of excellence. Policymakers and providers often focus on standardizing perioperative care bundles to ensure consistent outcomes across diverse health settings.

Asia-Pacific exhibits rapid capacity expansion in tertiary centers and growing interest in advanced surgical platforms, driven by demographic trends and investment in specialized training. This region balances aggressive technology adoption in urban centers with pragmatic pathways to scale minimally invasive techniques in community hospitals. Across all regions, cross-border collaboration, international training programs, and remote proctoring are facilitating skill transfer and helping harmonize clinical standards despite differing local constraints.

How competitive differentiation, integrated service offerings, and evidence-focused commercial models are redefining company strategies across the colectomy procedural ecosystem

Company-level dynamics within the colectomy ecosystem reveal a competitive environment shaped by product differentiation, service models, and partnership strategies. Leading device manufacturers are prioritizing systems integration, evidence generation, and surgeon-focused support to differentiate their offerings. This includes investments in modular instrumentation, single-use options optimized for workflow, and digital capabilities that support perioperative planning and outcome tracking.

Commercial strategies increasingly emphasize bundled solutions that combine hardware, disposables, training, and service commitments to reduce friction in adoption decisions. Manufacturers and distributors are also experimenting with outcomes-linked contracting and training-as-a-service models to demonstrate value beyond unit sales. Collaborative arrangements between technology providers and clinical centers support iterative product refinement and generate real-world evidence that informs clinical guidelines and payer conversations.

Finally, new entrants and niche innovators are focusing on unmet procedural pain points such as ergonomic enhancements, cost-effective disposable technologies, and tools that streamline anastomosis or specimen extraction. These focused innovations complement broader platform strategies and create pathways for targeted partnerships or licensing arrangements with established players to accelerate market access and clinical validation.

Actionable strategic moves for providers and industry stakeholders to accelerate safe adoption, control costs, and align clinical outcomes with commercial frameworks

Industry leaders can translate the observed trends into concrete initiatives that align clinical quality with operational and commercial objectives. First, prioritize investment in clinician training programs that accelerate safe adoption of minimally invasive and robotic-assisted techniques while embedding enhanced recovery principles to improve throughput and patient outcomes. Structured proctoring, simulation, and competency-based credentialing will reduce variability and enable predictable program expansion.

Second, strengthen cross-functional alignment between clinical leadership and supply chain teams to implement total-cost-of-care evaluations when selecting devices and platforms. Negotiated service-level agreements, transparent lifecycle costing, and clinically informed standardization can preserve access to advanced technologies while containing procedural expenditure. Third, explore flexible commercial arrangements with technology providers, such as bundled procurement, subscription models for instrumentation, and outcomes-linked contracts, to align incentives across stakeholders and reduce capital barriers to adoption.

Finally, accelerate data-driven quality programs that tie procedural choices to patient-reported outcomes and complication metrics. Investing in interoperable data capture and analytics enables continuous improvement, supports payer conversations, and differentiates centers of excellence. These pragmatic steps will help institutions balance clinical innovation with fiscal responsibility and position organizations to respond adaptively to ongoing market and policy shifts.

A mixed-methods research framework integrating clinical evidence, stakeholder interviews, and device performance insights to ensure balanced, practice-oriented conclusions

The research underpinning this executive summary synthesizes peer-reviewed clinical literature, guideline statements, procedural registries, device technical documentation, and interviews with clinical and supply chain leaders across multiple regions. A mixed-methods approach combined qualitative interviews with thematic analysis to surface practical barriers and enablers, while structured reviews of clinical evidence and device characteristics provided technical context for procedural and training implications.

Primary inputs included consultations with practicing colorectal and general surgeons, perioperative nursing leaders, surgical program directors, and hospital procurement professionals. These engagements were used to validate observations about workflow, training needs, device preferences, and the operational impacts of tariff policy adjustments. Secondary sources comprised guideline summaries, published comparative effectiveness assessments, and device labeling and performance specifications to ensure clinical fidelity.

Synthesis prioritized triangulation across evidence streams, favoring consistency of observation and corroboration by multiple stakeholder types. Where perspectives diverged, the analysis highlighted conditional factors and contextual drivers rather than asserting universal conclusions. This methodology ensures that the findings are grounded in clinical practice realities while transparently reflecting areas that require institution-level interpretation.

Synthesis of clinical, operational, and commercial imperatives that define strategic priorities for institutions navigating the evolving colectomy landscape

In conclusion, colectomy procedures are at a strategic crossroads where clinical innovation, operational redesign, and commercial dynamics intersect to create both opportunities and challenges for providers and industry partners. Minimally invasive and robotic-assisted techniques continue to advance clinical capability, while market and policy pressures underscore the importance of procurement agility and cost-conscious adoption strategies. The interplay of indication-specific requirements, procedural heterogeneity, and end-user environments necessitates tailored approaches that respect clinical nuance while enabling scalable implementation.

Organizations that invest in competency-based training, cross-functional procurement frameworks, and data-enabled quality programs will be best positioned to reconcile clinical aspirations with economic realities. Moreover, regional differences in capacity and reimbursement call for differentiated market and operational strategies that reflect local constraints and growth trajectories. Ultimately, success will hinge on collaborative models that align clinician priorities, supply chain rigor, and vendor commitments to deliver predictable patient outcomes and sustainable programmatic growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Colectomy Procedures Market, by Indication

  • 8.1. Cancer
  • 8.2. Crohn's Disease
  • 8.3. Diverticular Disease
  • 8.4. Ulcerative Colitis

9. Colectomy Procedures Market, by Surgical Approach

  • 9.1. Minimally Invasive
    • 9.1.1. Laparoscopic
    • 9.1.2. Robotic Assisted
  • 9.2. Open Surgery

10. Colectomy Procedures Market, by Procedure Type

  • 10.1. Partial Colectomy
    • 10.1.1. Left Hemicolectomy
    • 10.1.2. Right Hemicolectomy
    • 10.1.3. Sigmoid Colectomy
    • 10.1.4. Transverse Hemicolectomy
  • 10.2. Proctocolectomy
  • 10.3. Total Colectomy

11. Colectomy Procedures Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospital Surgical Centers
  • 11.3. Outpatient Clinics

12. Colectomy Procedures Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Colectomy Procedures Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Colectomy Procedures Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Colectomy Procedures Market

16. China Colectomy Procedures Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Applied Medical Resources Corporation
  • 17.7. B. Braun SE
  • 17.8. Baxter International Inc.
  • 17.9. Boston Scientific Corporation
  • 17.10. Cardinal Health Inc.
  • 17.11. Colospan Ltd.
  • 17.12. CONMED Corporation
  • 17.13. Cook Group Incorporated
  • 17.14. CooperSurgical Inc.
  • 17.15. Fujifilm Holdings Corporation
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johns Hopkins Medicine
  • 17.18. Johnson & Johnson Services, Inc.
  • 17.19. Karl Storz SE & Co. KG
  • 17.20. Medtronic PLC
  • 17.21. NuVasive, Inc.
  • 17.22. Olympus Corporation
  • 17.23. SafeHeal SAS
  • 17.24. Smith & Nephew PLC
  • 17.25. Stryker Corporation
  • 17.26. Virtual Incision Corporation
  • 17.27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLECTOMY PROCEDURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLECTOMY PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 130. GCC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 133. GCC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 151. G7 COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 152. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 154. G7 COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 158. NATO COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 159. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 161. NATO COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)